Early treatment with Jintropin, a form of human growth hormone, was associated with improvements in cognition and appeared to slow…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
The Foundation for Prader-Willi Research has awarded a two-year, $141,444 grant to help fund the development…
Compared to their typically developing peers, children with Prader-Willi syndrome show marked differences in the shapes and sizes of…
Bone health problems such as osteoporosis and scoliosis are common among people with Prader-Willi syndrome, a new study indicates.
Certain regions of the brain are unusually small in people with Prader-Willi syndrome (PWS), a study reveals. “The present…
Scoliosis — an abnormal sideways curvature of the spine — has a high prevalence among people with Prader-Willi syndrome…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
Starting treatment with growth hormone early in life — before age 2 — was associated with better cognitive and behavioral…
Recent changes to a Phase 2 clinical trial of the oral medicine pitolisant to treat excessive daytime sleepiness will make…
Dietary supplementation with conjugated linoleic acid led to weight loss in a mouse model of Prader-Willi syndrome (PWS), according…